Characterization of the patients with tuberculosis admitted in the Regional Hospital of Malabo. 2016
Keywords:
tuberculosis, diagnosis, sputum smear.Abstract
Introduction: More than a century ago, Robert Koch identified the microorganism causing tuberculosis in people: Mycobacterium tuberculosis. But it is still a serious epidemiologic problem around the world. The authors presented a study carried out in patients admitted in the Infectious Service of the Regional Hospital of Malabo.
Objective: to characterize the patients with tuberculosis admitted in the first stage of the anti-tuberculosis treatment.
Materials and methods: a descriptive, retrospective study was carried out on the patients who were admitted in the Infectious Service of the Regional Hospital of Malabo in the period from January to July 2016. The universe were 172 patients with diagnosis of tuberculosis in all its clinical forms. Data were gathered from the clinical records.
Results: male sex predominated in 57.5 % of the patients as it also did the 25-34 years-old age group with 33.7 %. Negative sputum smear represented 67.9 % of the cases and the most frequent nutritional status was the low weight with 50.9 %. Tuberculosis in its pulmonary form predominated in 95.9 % of the patients. 65.6 % of the patients were HIV negative. The clinical radiological improvement at the end of the treatment was 87.7 %.
Conclusions: 57.5 % of the patients were male aged 25-34 years old. Negative sputum smear and the pulmonary form of tuberculosis predominated. The clinical radiological improvement was higher at the end of the treatment.
Downloads
References
2. Silva Reyes I, Del Campo Mulet E, Nápoles Smith N, et al. Aspectos clinicoepidemiológicos en pacientes con coinfección por sida y tuberculosis en la provincia de Santiago de Cuba. MEDISAN[Internet]. 2016[citado 07/11/16];20(10). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192016001000010
3. Gómez Murcia PR, Farlane Martínez E, García Acosta R, et al. Magnitud de la pesquisa activa en diagnóstico de tuberculosis implementada en grupos vulnerables. Matanzas 2009-2013. Rev Méd Electrón[Internet]. 2016[citado 07/11/16]; 38(3): 351-60. Disponible en:http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S1684-18242016000300005&lng=es&nrm=iso
4. Houben GJ, Menzies NA, Sumner T, et al. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. Lancet Glob Health. 2016;4(11): e806-e815. Citado en PubMed; PMC6375908 .
5. World Health Organization. WHO Global Ministerial Conference. Ending tuberculosis in the SDG era: A multisectoral response [Internet]. Geneva: WHO; 2017 [citado el 29/01/ 16. Disponible en: http://www.who. int/conferences/tb-global-ministerialconference/en/.
6. Ministerio de Salud de la Federación Rusa. Se celebró una reunión de alto nivel en el Ministerio de Salud de Rusia con representantes autorizados de la sede de la OMS [Internet]. Moscú: Ministerio de Salud de Rusia; 2017 [citado 07/11/18]. Disponible en: https://www.who.int/tb/endtb-sdg-ministerial-conference/es/
7. World Health Organization. WHO End TB Strategy [Internet]. Geneva: WHO; 2016 [citado 7/11/16]. Disponible en: http://www.who.int/tb/ post2015_strategy/en/.
8. Peña C, Césped M, Wolff M, et al. Diagnóstico bacteriológico de tuberculosis pulmonar mediante fibrobroncoscopía en pacientes con VIH. Rev chilena de enfermedades respiratorias [Internet]. 2014[citado 7/11/16]; 30(1): 46-53. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_abstract&pid=S0717-73482014000100008&lng=es&nrm=iso
9. Contreras Rojas M. Nutrición y tuberculosis. Síntesis de la guía OMS, “La atención y apoyo nutricional a pacientes con tuberculosis”. Boletín-Instituto Nacional de Salud[Internet]. 2014[citado 7/11/16]; 20(5-6. Disponible en: https://repositorio.ins.gob.pe/xmlui/handle/INS/279
10. Stop TB Partnership. Accelerating action to meet the SDG TB targets: the case for a UN High Level Meeting on TB in 2017 [Internet]. Geneva: Stop TB Partnership; 2016 [citado 07/11/16]. Disponible en: http://www.stoptb.org/news/stories/2016/ns16_049.asp
11. Morales N, Beldarraín Chaple E. Aspectos económicos y sociales relacionados con el comportamiento de la tuberculosis en Cuba. Década de los 90. Medisur [Internet]. 2015 Abr[citado 07/11/16]; 13(2): 239-47. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2015000200004
12. Treatment Action Group / Stop TB Partnership. 2016 Report on Tuberculosis Research Funding Trends, 2005-2015: No Time to Lose [Internet]. New York: TAG; 2016 [citado 29/01/18]. Disponible en: http://www.treatmentactiongroup.org/sites/default/files/TB_FUNDING_2016_WEB.pdf.
13. Álvarez Escobar MC, Lima Gutiérrez H, Torres Alvarez A, et al. Síndrome de reconstitución inmune en un paciente de sida con una tuberculosis diseminada. Rev Méd Electrón [Internet]. 2017 Nov-Dic [citado 29/01/18];39(6). Disponible en:
http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/1818/3648
14. García CH, Cea LM, Espinilla VF, et al. Brote de tuberculosis resistente a isoniacida en una comunidad de inmigrantes en España. Archivos de Bronconeumología[Internet] 2016[citado 29/01/18]; 52(6): 289-92. Disponible en: https://www.archbronconeumol.org/es-brote-tuberculosis-resistente-isoniacida-una-articulo-S0300289615003221
15. Nobel Media AB. The Nobel Lecture: Current State of the Struggle against Tuberculosis [Internet]. Oslo: Nobel Media AB; 2014 [citado 07/11/16]. Disponible en: https://www.nobelprize.org/prizes/medicine/1905/koch/lecture/
16. World Health Organization / International Union Against Tuberculosis and Lung Disease Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-Tuberculosis Drug Resistance in the World - Report No. 2: Prevalence and Trends [Internet]. Geneva: WHO; 2000 [citado el 06/11/16]. Disponible en:
http://apps.who.int/iris/bitstream/10665/66493/1/WHO_CDS_TB_2000.278_intro. pdf?ua=1&ua=1.
Published
How to Cite
Issue
Section
License
All content published in this journal is Open Access, distributed under the terms of the CC BY-NC 4.0 License.
It allows:
- Copy and redistribute published material in any medium or format.
- Adapt the content.
This will be done under the following terms:
- Attribute the authors' credits and indicate whether changes were made, in which case it must be in a reasonable way.
- Non-commercial use.
- Recognize the journal where it is published.
The copyrights of each article are maintained, without restrictions.
Guidelines to authors
